These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1806185)

  • 21. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
    Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
    Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of IL-6 signal transduction pathway in a human multiple myeloma cell line--Sko-007].
    Song L; Li Y; Shen B
    Zhonghua Xue Ye Xue Za Zhi; 2000 Nov; 21(11):569-71. PubMed ID: 11225245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth.
    Jelinek DF; Witzig TE; Arendt BK
    J Immunol; 1997 Jul; 159(1):487-96. PubMed ID: 9200490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.
    Borsellino N; Belldegrun A; Bonavida B
    Cancer Res; 1995 Oct; 55(20):4633-9. PubMed ID: 7553641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma-derived cervical cells in vitro.
    Iglesias M; Plowman GD; Woodworth CD
    Am J Pathol; 1995 Apr; 146(4):944-52. PubMed ID: 7717461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
    Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
    Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomics and proteomics in multiple myeloma and Waldenström macroglobulinemia.
    Henry T; Fonseca R
    Curr Opin Hematol; 2007 Jul; 14(4):369-74. PubMed ID: 17534163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo models for studying the role of autocrine or paracrine growth factors in hematologic malignancies.
    Soma T; Dunbar CE
    Exp Hematol; 1995 May; 23(5):385-8. PubMed ID: 7720810
    [No Abstract]   [Full Text] [Related]  

  • 29. [Waldenström's macroglobulinemia with cerebral lymphoproliferative involvement of tumor appearance (Bing and Neel syndrome). An anatomo-clinical case].
    Quilichini R; Benderitter T; Lafeuillade A; Chaffanjon P; Aubert L
    Ann Med Interne (Paris); 1989; 140(1):25-9. PubMed ID: 2500048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N; Colla S; Morandi F; Rizzoli V
    Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
    Owen RG
    Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cells.
    Collette M; Descamps G; Pellat-Deceunynck C; Bataille R; Amiot M
    Eur Cytokine Netw; 2007 Sep; 18(3):120-6. PubMed ID: 17823079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of interferon-alpha and -gamma on B cell differentiation in macroglobulinemia.
    Levy Y; Chedeville A; Brouet JC
    Leuk Lymphoma; 1996 Oct; 23(3-4):347-51. PubMed ID: 9031116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lung involvement in lymphoid and lympho-plasmocytic proliferations (except lymphomas)].
    Uzunhan Y; Cadranel J; Boissel N; Gardin C; Arnulf B; Bergeron A
    Rev Mal Respir; 2010 Jun; 27(6):599-610. PubMed ID: 20610075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of interleukin-6 in multiple myeloma.
    Bataille R; Klein B
    Ann Med Interne (Paris); 1992; 143 Suppl 1():77-9. PubMed ID: 1300892
    [No Abstract]   [Full Text] [Related]  

  • 36. IgM myeloma: different features from multiple myeloma and macroglobulinaemia.
    Kondo H; Yokoyama K
    Eur J Haematol; 1999 Nov; 63(5):366-8. PubMed ID: 10580573
    [No Abstract]   [Full Text] [Related]  

  • 37. [Myeloma cell growth and interleukin 6].
    Takahashi T
    Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1122-6. PubMed ID: 7561370
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemodynamic disturbances in macroglobulinemia and myeloma.
    JAMA; 1969 Apr; 208(4):686. PubMed ID: 4976040
    [No Abstract]   [Full Text] [Related]  

  • 39. Priapism in Lymphoproliferative Disorders: A Systematic Review.
    Ali EA; Sardar S; Yassin MA
    Hematol Oncol Stem Cell Ther; 2022 Dec; 15(4):176-182. PubMed ID: 34157311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophages as an important source of paracrine IL6 in myeloma bone marrow.
    Durie BG; Vela EE; Frutiger Y
    Curr Top Microbiol Immunol; 1990; 166():33-6. PubMed ID: 2073813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.